Illegal Marketing of Relieva Stratus MicroFlow Spacer Results in $18M Settlement by J&J Unit
A whistleblower lawsuit has resulted in Johnson & Johnson subsidiary Acclarent paying $18 million to settle federal claims that it illegally marketed a drug delivery system without FDA approval.